The London-based healthtech company, which lets clinicians practise emergencies and difficult conversations in virtual reality, will use the capital to deepen its US footprint and accelerate AI-driven product development. Oxford Medical Simulation has raised £5 million in growth financing from Salica Investments, the London-based investment firm formerly known as Hambro Perks. The funding will support […]
This story continues at The Next Web